Showing 225 results

Filters Content type: News, Editors' picks Topic: Injectable & long-acting HIV treatment

Research into injectable medications and other innovative forms of HIV treatment. It is hoped that they may only need to be taken every few weeks or months, rather than daily.

 

People with limited treatment options

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows

News
2 November 2018
Injectable & long-acting PrEP

Beyond Truvada – what is the future of PrEP?

News
31 October 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
New & experimental HIV treatments

First large HIV prevention trial using antibodies will probably not be the last

News
29 October 2018
Injectable & long-acting PrEP

The long tail of injectable PrEP is especially long for women

News
25 October 2018
Injectable & long-acting HIV treatment

Wide range of views about switching to weekly, monthly or biannual ART

News
15 October 2018
New & experimental HIV treatments

Long-acting injectable implant shows promise for HIV treatment and prevention

Editor's pick
University of North Carolina
9 October 2018
New & experimental HIV treatments

Dual-antibody combination therapy produces three to seven months of viral suppression without pills

News
8 October 2018
People with limited treatment options

Ibalizumab Provides New Option for Patients with Multidrug-Resistant HIV

Editor's pick
MD Magazine
23 August 2018
Injectable & long-acting HIV treatment

Swapping daily pills for monthly shots could transform HIV treatment and prevention

Editor's pick
Science
23 August 2018
New & experimental HIV treatments

Should Gilead Be Worried About This New Monthly HIV Medication?

Editor's pick
Motley Fool
16 August 2018
New & experimental HIV treatments

Is the World Ready for Long-Acting HIV Treatment?

Editor's pick
The Body Pro
11 June 2018
New & experimental HIV treatments

China approves Albuviritide: first domestically developed, long-acting injectable anti-HIV drug

Editor's pick
Firstpost
6 June 2018
New & experimental HIV treatments

Ibalizumab-uiyk for HIV: What Pharmacists Should Know

Editor's pick
Pharmacy Times
27 March 2018
New & experimental HIV treatments

Powerful new PrEP and treatment drug should be effective as a small weekly pill

News
12 March 2018
New & experimental HIV treatments

Ibalizumab, active against highly resistant HIV, now approved in US

News
8 March 2018
Injectable & long-acting PrEP

Long-acting injectable ARVs are convenient and private, study participants report

News
17 January 2018
Injectable & long-acting HIV treatment

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

News
9 January 2018
New & experimental HIV treatments

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

Editor's pick
Yale News
8 January 2018
New & experimental HIV treatments

HIV Drugs in the Pipeline: Expected Approvals for 2018

Editor's pick
Infectious Disease Special Edition
31 December 2017
HIV treatment

Top 10 HIV Clinical Developments of 2017

Editor's pick
The Body Pro
19 November 2017
Antibody-based treatment

Long-acting monoclonal antibody effective against multidrug-resistant HIV

News
12 October 2017
New & experimental HIV treatments

Promising HIV Treatments in Late-Stage Clinical Development

Editor's pick
P&T Community
2 October 2017
New & experimental HIV treatments

Long-acting NRTI shows promise for HIV treatment and PrEP

News
2 August 2017